Jeff Yass’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Jeff Yass’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-63,710	Closed	-$2.23M	–	13636
2024 Q1	$2.23M	Sell	63,710 -42,485	-40%	-$1.55M	﹤0.01%	5070
2023 Q4	$4.04M	Buy	106,195 +77,242	+267%	+$1.66M	﹤0.01%	4084
2023 Q3	$531K	Buy	28,953 +3,304	+13%	+$69.1K	﹤0.01%	8078
2023 Q2	$666K	Sell	25,649 -45,487	-64%	-$1.06M	﹤0.01%	7639
2023 Q1	$1.34M	Buy	71,136 +55,262	+348%	+$1.29M	﹤0.01%	6079
2022 Q4	$391K	Sell	15,874 -29,093	-65%	-$855K	﹤0.01%	8438
2022 Q3	$807K	Buy	44,967 +13,810	+44%	+$249K	﹤0.01%	7194
2022 Q2	$354K	Sell	31,157 -992	-3%	-$14.6K	﹤0.01%	9118
2022 Q1	$716K	Sell	32,149 -12,647	-28%	-$323K	﹤0.01%	8022
2021 Q4	$1.96M	Buy	+44,796	New	+$1.79M	﹤0.01%	5560

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jeff Yass's INBX Position: Q2 2024 in Review

Jeff Yass sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 63,710 shares — an estimated $2.23M sold.

Jeff Yass first reported a position in INBX in Q4 2021 and held it in 10 quarters. The position peaked at $4.04M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Jeff Yass reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jeff Yass sold 63,710 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $2.23M.
Jeff Yass first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Jeff Yass's Inhibrx, Inc. Common Stock position peaked at $4.04M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.